Zobrazeno 1 - 10
of 10
pro vyhledávání: '"C Herrmann"'
Autor:
Leo Marcoff, Josep Rodés-Cabau, Robert L. Smith, Ian J. Sarembock, Pinak B. Shah, George Petrossian, Howard C. Herrmann, Chad Kliger, Amit N. Vora, Susheel Kodali, Charles J. Davidson, Samir R. Kapadia, Homam Ibrahim, Linda D. Gillam, Abhijeet Dhoble, Andrew N. Rassi, Mayra Guerrero, Lowell F. Satler, David P. Lee, Paul Mahoney, D. Scott Lim, Adnan K. Chhatriwalla, Clasp Iid Pivotal Trial Investigators, Roger J. Laham, Mohamad Lazkani, William A. Gray, Konstantinos Koulogiannis, Adam Greenbaum, Firas Zahr, James B. Hermiller
Publikováno v:
Catheterization and Cardiovascular Interventions.
OBJECTIVES We report the 30-day outcomes from the roll-in cohort of the CLASP IID trial, representing the first procedures performed by each site. BACKGROUND The currently enrolling CLASP IID/IIF pivotal trial is a multicenter, prospective, randomize
Autor:
Kaijun Wang, Mathew R. Williams, John G. Webb, Michael T. Lu, Suzanne J. Baron, Khaja Chinnakondepalli, Craig R. Smith, Howard C. Herrmann, Samir R. Kapadia, Elizabeth A. Magnuson, Alan Zajarias, Michael J. Mack, Partner Investigators, Dean J. Kereiakes, Raj Makkar, David J. Cohen, Susheel Kodali, Vinod H. Thourani, Maria Alu, Vasilis Babaliaros, Martin B. Leon
Publikováno v:
Journal of the American College of Cardiology. 74(23)
In patients with severe aortic stenosis (AS) at low surgical risk, treatment with transcatheter aortic valve replacement (TAVR) results in lower rates of death, stroke, and rehospitalization at 1 year compared with surgical aortic valve replacement;
Autor:
Craig R. Smith, Jeevanantham Rajeswaran, Samir R. Kapadia, David Cohen, Chetan Huded, Suzanne J. Baron, Eugene H. Blackstone, Michael J. Mack, Molly Szerlip, Martin B. Leon, Susheel Kodali, John G. Webb, Raj Makkar, E. Murat Tuzcu, Howard C. Herrmann, D. Craig Miller, Lars G. Svensson, Vinod H. Thourani
Publikováno v:
Journal of the American College of Cardiology. 72(20)
Transfemoral-transcatheter aortic valve replacement (TF-TAVR) is increasingly used to treat aortic stenosis, but risk of post-procedure stroke is uncertain.The purpose of this study was to assess stroke risk and its association with quality of life a
Autor:
Martin B. Leon, Michael J. Mack, Howard C. Herrmann, Susheel Kodali, Khaja Chinnakondepali, Vinod H. Thourani, Suzanne V. Arnold, Kaijun Wang, David L. Brown, Raj Makkar, David J. Cohen, Craig R. Smith, Elizabeth A. Magnuson, Lars G. Svensson, Samir R. Kapadia, Suzanne J. Baron
Publikováno v:
JAMA cardiology. 2(8)
In patients with severe aortic stenosis (AS) at intermediate surgical risk, treatment with transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) results in similar 2-year survival. The effect of TAVR vs SAVR on hea
Autor:
Martin B. Leon, John A. Spertus, Ajay J. Kirtane, Suzanne V. Arnold, Yang Lei, Nirat Beohar, Michael J. Mack, Samir R. Kapadia, Vinod H. Thourani, Alan Zajarias, Philip Green, David Cohen, Howard C. Herrmann
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 6:591-597
Background— Transcatheter aortic valve replacement (TAVR) has emerged as a less invasive option for valve replacement of patients with severe aortic stenosis. Although it has been recommended that TAVR should not be offered to patients who will not
Autor:
Gabriel S. Aldea, Vasilis Babaliaros, David Cohen, Wilson Y. Szeto, Larry S. Dean, Howard C. Herrmann, Martin B. Leon, James M. McCabe, Raj Makkar, Jeevanantham Rajeswaran, John Ehrlinger, Michael J. Mack, Creighton W. Don, Eugene H. Blackstone, Bradley G. Leshnower, Lars G. Svensson, Mathew R. Williams, Susheel Kodali, Augusto D. Pichard, Vinod H. Thourani, Hersh S. Maniar, Samir R. Kapadia, Gorav Ailawadi, Hanna A. Jensen, Rakesh M. Suri, Rebecca T. Hahn, Chandan Devireddy
Publikováno v:
The Annals of thoracic surgery. 100(3)
Background This study describes short-term and mid-term outcomes of nonagenarian patients undergoing transfemoral or transapical transcatheter aortic valve replacement (TAVR) in the Placement of Aortic Transcatheter Valve (PARTNER)-I trial. Methods F
Autor:
Andrew Wang, Ted Feldman, Michael J. Mack, D. Scott Lim, Paul A. Grayburn, Matthew R. Reynolds, William A. Gray, Howard C. Herrmann, Patrick L. Whitlow, Donald D. Glower, Saibal Kar
Publikováno v:
Journal of the American College of Cardiology. 64(2)
BackgroundSurgical mitral valve repair (SMVR) remains the gold standard for severe degenerative mitral regurgitation (DMR). However, the results with transcatheter mitral valve repair (TMVR) in prohibitive-risk DMR patients have not been previously r
Autor:
Ullrich Buss, Christian Wantzen, C. Herrmann, Anselm Schaumann, Friederike von zur Mühen, Sylke Kemper, Gonska Bd
Publikováno v:
Pacing and Clinical Electrophysiology. 20:95-103
The ICD has become a standard treatment for patients with malignant arrhythmias. Despite its benefits it may cause additional discomfort to the patients. Thus, quality-of-life needs to be assessed in these patients. Previous studies have used only sm
Autor:
Yang Lei, Martin B. Leon, Vasilis Babaliaros, Susheel Kodali, Bruce Bowers, Howard C. Herrmann, Elizabeth A. Magnuson, Samir Kapadia, John G. Webb, Matthew R. Reynolds, Craig R. Smith, William F. Fearon, Raj Makkar, David J. Cohen, Lars G. Svensson, Augusto Pichard
Publikováno v:
Circulation. 124(18)
Background— Transcatheter aortic valve replacement (TAVR) has been shown to improve survival compared with standard therapy in patients with severe aortic stenosis who cannot have surgery. The effects of TAVR on health-related quality of life have
Autor:
Brian Whisenant, Mauricio G. Cohen, Howard C. Herrmann, Samir R. Kapadia, Gregory P. Fontana, Wen Cheng, Paul S. Teirstein, Mathew R. Williams, Tarun Chakravarty, David Cohen, Hasan Jilaihawi, Vasilis Babaliaros, Craig R. Smith, Ke Xu, Susheel Kodali, E. Murat Tuzcu, Joseph E. Bavaria, Martin B. Leon, John G. Webb, Vinod H. Thourani, Michael J. Mack, Raj Makkar, Augusto D. Pichard, Alfredo Trento
Publikováno v:
Journal of the American College of Cardiology. (9):901-911
ObjectivesThe goal of this study was to examine the impact of reasons for surgical inoperability on outcomes in patients undergoing transcatheter aortic valve replacement (TAVR).BackgroundPatients with severe aortic stenosis may be deemed inoperable